Total Payments
$2,886
2023 Payments
$81.88
Companies
16
Transactions
183
Medicare Patients
6,912
Medicare Billing
$752,992
Payment Breakdown by Category
Food & Beverage$2,886 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,886 | 183 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $522.13 | 38 | $0 (2023) |
| Amgen Inc. | $422.57 | 24 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $406.46 | 29 | $0 (2022) |
| Abbott Laboratories | $370.03 | 25 | $0 (2022) |
| PFIZER INC. | $331.90 | 19 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $284.46 | 18 | $0 (2022) |
| Medtronic Vascular, Inc. | $145.13 | 4 | $0 (2018) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $88.96 | 7 | $0 (2019) |
| Merck Sharp & Dohme LLC | $73.68 | 5 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $67.41 | 4 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $81.88 | 4 | Merck Sharp & Dohme LLC ($33.85) |
| 2022 | $302.50 | 17 | E.R. Squibb & Sons, L.L.C. ($113.46) |
| 2021 | $278.04 | 16 | Abbott Laboratories ($119.28) |
| 2020 | $433.49 | 27 | Abbott Laboratories ($110.07) |
| 2019 | $715.47 | 53 | Janssen Pharmaceuticals, Inc ($167.65) |
| 2018 | $551.17 | 36 | Janssen Pharmaceuticals, Inc ($113.64) |
| 2017 | $523.05 | 30 | Medtronic Vascular, Inc. ($109.80) |
All Payment Transactions
183 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/23/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/18/2023 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $24.21 | General |
| Category: Cardiovascular | ||||||
| 03/29/2023 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/13/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $23.82 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/19/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $15.02 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 11/09/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | Food and Beverage | Cash or cash equivalent | $11.93 | General |
| Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/18/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.18 | General |
| Category: Cardiovascular | ||||||
| 10/11/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/11/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $23.27 | General |
| Category: Cardiovascular | ||||||
| 07/06/2022 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/28/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $15.46 | General |
| Category: Cardiovascular | ||||||
| 06/15/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/25/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $18.06 | General |
| Category: Cardiovascular | ||||||
| 04/28/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $23.66 | General |
| Category: Cardiology | ||||||
| 04/21/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.17 | General |
| Category: Cardiovascular | ||||||
| 04/13/2022 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/31/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/21/2022 | Abbott Laboratories | ALLURE QUADRA (Device) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiac Rhythm Management | ||||||
| 03/17/2022 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Cardiology | ||||||
| 02/22/2022 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/09/2022 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.32 | General |
| Category: Cardiovascular | ||||||
| 12/07/2021 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/06/2021 | Abbott Laboratories | Confirm Rx (Device) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Cardiac Rhythm Management | ||||||
| 12/02/2021 | Abbott Laboratories | CardioMEMS HF System (Device) | Food and Beverage | In-kind items and services | $18.67 | General |
| Category: Heart Failure | ||||||
| 11/23/2021 | Abbott Laboratories | Assurity Pacemaker (Device) | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: Cardiac Rhythm Management | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 588 | 672 | $147,304 | $36,708 |
| 2022 | 19 | 1,955 | 2,671 | $646,881 | $202,714 |
| 2021 | 21 | 2,151 | 3,220 | $817,532 | $268,064 |
| 2020 | 20 | 2,218 | 3,208 | $818,276 | $245,506 |
Total Patients
6,912
Total Services
9,771
Medicare Billing
$752,992
Procedure Codes
73
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 132 | 169 | $44,278 | $11,910 | 26.9% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 62 | 62 | $33,852 | $7,318 | 21.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 134 | 148 | $26,344 | $6,357 | 24.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 21 | 23 | $11,500 | $2,839 | 24.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 21 | $5,418 | $1,944 | 35.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $7,042 | $1,703 | 24.2% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 31 | 32 | $5,056 | $1,623 | 32.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 15 | 20 | $3,560 | $1,221 | 34.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 152 | 171 | $8,550 | $1,217 | 14.2% |
| 93280 | Programming of dual lead pacemaker system | Office | 2023 | 12 | 12 | $1,704 | $577.56 | 33.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 363 | 661 | $173,182 | $57,276 | 33.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 210 | 211 | $115,206 | $31,616 | 27.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 134 | 176 | $61,952 | $23,252 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 271 | 371 | $66,038 | $22,453 | 34.0% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 38 | 38 | $44,004 | $12,779 | 29.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 68 | 68 | $34,204 | $10,312 | 30.1% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 41 | 48 | $24,000 | $7,176 | 29.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 38 | 152 | $20,976 | $7,030 | 33.5% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 33 | 72 | $18,576 | $5,687 | 30.6% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 87 | 91 | $14,378 | $4,898 | 34.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 447 | 506 | $25,300 | $4,659 | 18.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 31 | 31 | $12,400 | $3,402 | 27.4% |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 2022 | 37 | 37 | $4,648 | $3,237 | 69.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 35 | 55 | $9,790 | $3,025 | 30.9% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 38 | 38 | $8,360 | $1,566 | 18.7% |
About Dr. Steven Feld, MD
Dr. Steven Feld, MD is a Cardiovascular Disease healthcare provider based in Lufkin, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1699784603.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Feld, MD has received a total of $2,886 in payments from pharmaceutical and medical device companies, with $81.88 received in 2023. These payments were reported across 183 transactions from 16 companies. The most common payment nature is "Food and Beverage" ($2,886).
As a Medicare-enrolled provider, Feld has provided services to 6,912 Medicare beneficiaries, totaling 9,771 services with total Medicare billing of $752,992. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Ad
Practice Information
- Specialty Cardiovascular Disease
- Location Lufkin, TX
- Active Since 08/07/2006
- Last Updated 02/16/2017
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1699784603
Products in Payments
- ELIQUIS (Drug) $795.01
- XARELTO (Drug) $406.46
- Corlanor (Drug) $319.18
- ENTRESTO (Drug) $267.73
- Reveal LINQ (Device) $109.80
- Repatha (Biological) $103.39
- Confirm Rx (Device) $101.64
- PRADAXA (Drug) $75.46
- VERQUVO (Drug) $73.68
- CardioMEMS HF System (Device) $70.92
- PRALUENT (Drug) $67.41
- CHANTIX (Drug) $59.02
- LifeVest (Device) $43.41
- MVP (Device) $35.33
- Quadra Assura CRT Defibrillator (Device) $34.84
- BYSTOLIC (Drug) $28.32
- CROSSER (Device) $27.94
- Assurity Pacemaker (Device) $27.86
- Connectivity and Remote care (Device) $24.93
- INGENIO (Device) $23.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Lufkin
Ravinder Bachireddy, M.d, M.D
Cardiovascular Disease — Payments: $109,327
Cardiovascular Disease $109,327
Dr. Vivek Mangla, M.d, M.D
Cardiovascular Disease — Payments: $75,231
Cardiovascular Disease $75,231
Rohit Kedia, Md, MD
Cardiovascular Disease — Payments: $53,707
Cardiovascular Disease $53,707
Amirreza Solhpour, M.d, M.D
Cardiovascular Disease — Payments: $25,749
Cardiovascular Disease $25,749
Dr. Subramanya Gajaraju Venkata, M.d, M.D
Cardiovascular Disease — Payments: $11,436
Cardiovascular Disease $11,436
Ilyas Khan, M.d, M.D
Cardiovascular Disease — Payments: $10,675
Cardiovascular Disease $10,675